Chen Xiaomei, Lai Peilong, Wang Yulian, He Chang, Wu Suijing, Huang Xin, Geng Suxia, Luo Chengwei, Ling Wei, Zeng Lingji, Li Peng, Jiang Zhiwu, Weng Jianyu, Du Xin
The Second School of Clinical Medical, Southern Medical University Guangzhou 510515, P. R. China.
Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences Guangzhou 510080, Guangdong, P. R. China.
Am J Transl Res. 2018 Jul 15;10(7):2148-2157. eCollection 2018.
Chronic graft-versus-host disease (cGVHD) manifests with features characteristic of autoimmune disease with organs attacked by pathogenic Th17 cells. However, the mechanism of Th17 cells generation in the setting of cGVHD is still unclear. Here we defined C5a/C5aR-IL-17Aaxis as a novel signaling that required in the pathologies of cGVHD. We firstly found a positive link between complement activation and the Th17 cells in patients with cGVHD. C5a, a critical component of complements, promoted the generation of Th17 cells and inhibition of the receptor for C5a (C5aR) reduced the Th17-bias response. Of note, C5aR blockade by PMX53 could suppress the generation of IL-17A-expressing Th17 cells and retard the onset and progression of cGVHD . Overall, our results provide new mechanistic insights that activation of C5a-C5aR signaling was required for IL-17A-induced immune responses in cGVHD and define novel molecular targets for developing effective therapeutics for cGVHD.
慢性移植物抗宿主病(cGVHD)表现出自身免疫性疾病的特征,其器官受到致病性Th17细胞的攻击。然而,cGVHD背景下Th17细胞产生的机制仍不清楚。在此,我们将C5a/C5aR-IL-17A轴定义为cGVHD病理过程中所需的一种新信号通路。我们首先发现cGVHD患者补体激活与Th17细胞之间存在正相关。补体的关键成分C5a可促进Th17细胞的产生,而抑制C5a受体(C5aR)可减少Th17偏向性反应。值得注意的是,PMX53阻断C5aR可抑制表达IL-17A的Th17细胞的产生,并延缓cGVHD的发生和进展。总体而言,我们的结果提供了新的机制见解,即C5a-C5aR信号通路的激活是cGVHD中IL-17A诱导的免疫反应所必需的,并确定了开发cGVHD有效治疗方法的新分子靶点。